Eli Lilly CFO Lucas Montarce said on Monday it is preparing ​to launch its new oral obesity drug, ‌orforglipron, in the United States as early as the second quarter of this year, once it gets approval ...
The FDA has approved a once-weekly therapy to improve growth for children aged 2 years and older with achondroplasia, according to an industry press release.Navepegritide (Yuviwel, Ascendis Pharma), a ...
The approval follows PEGASUS Phase III trial assessing Palynziq efficacy and safety compared to diet alone in adolescents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results